Media coverage about HealthStream (NASDAQ:HSTM) has trended somewhat positive recently, according to Accern. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. HealthStream earned a coverage optimism score of 0.08 on Accern’s scale. Accern also assigned news coverage about the technology company an impact score of 46.1255336990664 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Shares of HealthStream (HSTM) opened at $24.40 on Friday. HealthStream has a fifty-two week low of $20.60 and a fifty-two week high of $31.53. The company has a market capitalization of $751.16, a P/E ratio of 135.56, a P/E/G ratio of 4.99 and a beta of 0.91.
HealthStream (NASDAQ:HSTM) last posted its quarterly earnings results on Monday, October 23rd. The technology company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.05 by $0.03. HealthStream had a return on equity of 2.46% and a net margin of 2.36%. The firm had revenue of $63.60 million during the quarter, compared to analysts’ expectations of $62.48 million. During the same quarter last year, the firm earned $0.04 earnings per share. The business’s revenue for the quarter was up 8.9% on a year-over-year basis. research analysts predict that HealthStream will post 0.23 earnings per share for the current fiscal year.
Several research firms recently commented on HSTM. Zacks Investment Research cut HealthStream from a “hold” rating to a “sell” rating in a report on Wednesday, January 3rd. Needham & Company LLC reaffirmed a “hold” rating and issued a $26.00 price target on shares of HealthStream in a report on Tuesday, October 24th. Canaccord Genuity reaffirmed a “hold” rating and issued a $25.00 price target on shares of HealthStream in a report on Monday, October 23rd. ValuEngine raised HealthStream from a “sell” rating to a “hold” rating in a report on Wednesday, January 3rd. Finally, Robert W. Baird cut their price target on HealthStream from $30.00 to $28.00 and set an “outperform” rating for the company in a report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $24.83.
ILLEGAL ACTIVITY WARNING: This story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/12/healthstream-hstm-receives-news-sentiment-score-of-0-08.html.
HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.